#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Arterial hypertension and sleep apnoea syndrome (review)


Authors: Genzor S. 1;  Kolek V. 1;  Václavík J. 2
Authors‘ workplace: Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc 2 I. interní klinika –  kardiologická LF UP a FN Olomouc 1
Published in: Kardiol Rev Int Med 2018, 20(4): 304-306

Overview

Sleep apnoea syndrome is the most common sleep-related breath­ing disorder. Its comorbidities may reduce not only the quality of life but the life expectancy of the patients as well. The association of sleep apnoea syndrome with cardiovascular dis­eases has been confirmed repeatedly. In the review, we summarize the main pathophysiological mechanisms lead­ing to the higher incidence of arterial hypertension in sleep apnoea patients, the clinical consequences of the relationship between sleep apnoea and arterial hypertension, and the implications in ther­apy. The ther­apy of sleep apnoea patients has to be comprehensive; an appropriate treatment may lower the elevated blood pressure and the over­all cardiovascular risk.

Key words:

sleep apnoea – arterial hypertension – cardiovascular risk – CPAP


Sources

1. International clas­sification of sleep disorders. (3rd ed). Darien, IL USA: American Academy of Sleep Medicine 2014.

2. Javaheri S. Sleep-related breath­­ing disorders in heart failure. In: Mann DL (ed.) Heart failure: a companion to braunwald's heart dis­ease. Saunders: Philadelphia, PA, USA, 2003, 478.

3. Klozar J, Plzák J, Ondrová M et al. Doporučený postup u dospělých pa­cientů s poruchami dýchání ve spánku. Česká společnost pro výzkum spánku a spánkovou medicínu, 2016. Dostupné na: http://www.sleep-society.cz/images/odborne/doporucene-postupy/Guidelines-2016-def-13.9.pdf.

4. Kamasova M, Vaclavik J, Vaclavik T et al. Ambulatory screen­­ing for obstructive sleep apnea in patients with resistant arterial hypertension. Sleep Breath 2018; 22(2): 361–367. doi: 10.1007/s11325-017-1583-5.

5. Ford ES. Trends in mortality from all causes and cardiovascular dis­ease among hypertensive and nonhypertensive adults in the United States. Circulation 2011; 123(16): 1737–1744. doi: 10.1161/CIRCULATIONAHA.110.005645.

6. Viera AJ. Hypertension update: cur­rent guidelines. FP Es­sent 2018; 469: 11–15.

7. Meng F, Ma J, Wang W et al. Obstructive sleep apnea syndrome is a risk factor of hypertension. Minerva Med 2016; 107(5): 294–299.

8. Wang S, Niu X, Zang P et al. Analysis of OSAS incidence and influential factors in middle-aged and elderly patients with hypertension. Minerva Med 2018. doi: 10.23736/S0026-4806.18.05635-5.

9. Xia W, Huang Y, Peng B et al. Relationship between obstructive sleep apnoea syndrome and es­sential hypertension: a dose-response meta-analysis. Sleep Med 2018; 47: 11–18. doi: 10.1016/j.sleep.2018.03.016.

10. Hou H, Zhao Y, Yu W et al. As­sociation of obstructive sleep apnea with hypertension: A systematic review and meta-analysis. J Glob Health 2018; 8(1): 010405. doi: 10.7189/jogh.08.010405.

11. Zhang W, Si LY. Obstructive sleep apnea syndrome (OSAS) and hypertension: Pathogenic mechanisms and pos­sible therapeutic approaches. Ups J Med Sci 2012; 117(4): 370–382. doi: 10.3109/03009734.2012.707253.

12. McEvoy RD, Antic NA, Heeley E, Luo Y al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016; 375(10): 919–931. doi: 10.1056/NEJMoa1606599.

13. Walia HK, Grif­fith, SD, Foldvary-Schaefer N et al. Longitudinal ef­fect of CPAP on BP in resistant and nonresistant hypertension in a large clinic-based cohort. Chest 2016; 149(3): 747–755. doi: 10.1378/chest.15-0697.

14. Sova M, Sovova E, Hobzova M et al. The ef­fect of continuous positive airway pres­sure ther­apy on the prevalence of masked hypertension in obstructive sleep apnea patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015; 159(2): 277–282. doi: 10.5507/bp.2014.063.

15. Martínez-García MA, Capote F, Campos-Rodríguez F et al. Ef­fect of CPAP on blood pres­sure in patients with obstructive sleep apnea and resistant hypertension The HIPARCO randomized clinical trial. JAMA 2013; 310(22): 2407–2415. doi: 10.1001/jama.2013.281250.

16. Chirinos JA, Gurubhagavatula I, Teff K et al. CPAP, weight los­s, or both for obstructive sleep apnea. N Engl J Med 2014; 370(24): 2265–2275. doi: 10.1056/NEJMoa1306187.

17. Lysdahl M, Haralds­son PO. Long-term survival after uvulopalatopharyngoplasty in nonobese heavy snorers: a 5- to 9 - year fol­low-up of 400 consecutive patients. Arch Otolaryngol Head Neck Surg 2000; 126(9): 1136–1140.

18. Iftikhar IH, Hays ER, Iverson MA et al. Ef­fect of oral appliances on blood pres­sure in obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 2013; 9(2): 165–174. doi: 10.5664/jcsm.2420.

Labels
Paediatric cardiology Internal medicine Cardiac surgery Cardiology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#